HIGHLIGHTS
- who: MDPI from the Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Parma, Italy have published the Article: Comparing the Efficacy and Safety Profile of Triple Fixed‐Dose Combinations in COPD: A Meta‐Analysis and IBiS Score, in the Journal: (JOURNAL)
SUMMARY
Combining an inhaled corticosteroid (ICS) with a long‐acting β2‐adrenoceptor ago‐ nist (LABA) and a long‐acting muscarinic antagonist (LAMA) in a fixed‐dose combination (FDC) is a keystone in the treatment of severe forms of chronic obstructive pulmonary disease (COPD). The current triple FDCs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.